Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors [Ann Oncol, 26, (2015), 2125-2132] doi: 10.1093/annonc/mdv310

Y. Nieto, S. M. Tu, R. Bassett, R. B. Jones, A. M. Gulbis, N. Tannir, A. Kingham, C. Ledesma, K. Margolin, L. Holmberg, R. Champlin, L. Pagliaro

Research output: Contribution to journalComment/debatepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)2507-2508
Number of pages2
JournalAnnals of Oncology
Issue number12
StatePublished - Dec 1 2015

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this